Evidence map›Paper›PMID 29789461›Full record

ArticlePharmacy (Basel, Switzerland)2018

Co-Morbidities as Predictors of Airflow Limitation among Smokers in England.

Reem Kayyali, Yusur Hassan, Iman Hesso, Roshan Siva

Abstract read
In one paragraph

Article in Pharmacy (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Reem KayyaliSchool of Life Sciences, Pharmacy and Chemistry, Kingston University London, Penrhyn Road, Kingston Upon Thames KT1 2EE, UK. R.Kayyali@kingston.ac.uk.
Yusur HassanSchool of Life Sciences, Pharmacy and Chemistry, Kingston University London, Penrhyn Road, Kingston Upon Thames KT1 2EE, UK. k1039336@kingston.ac.uk.
Iman HessoSchool of Life Sciences, Pharmacy and Chemistry, Kingston University London, Penrhyn Road, Kingston Upon Thames KT1 2EE, UK. hesso.iman@gmail.com.ORCID 0000-0002-6205-8692
Roshan SivaCroydon Health Services NHS Trust, Lennard Road, Croydon CR7 7YE, UK. roshan.siva@nhs.net.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of co-morbidities among patients with Chronic Obstructive Pulmonary Disease (COPD) is well documented in the literature. Therefore, this pilot study aimed to identify whether co-morbidities screening would enhance COPD case-finding. Smoking patients were approached at Croydon University Hospital and two local community pharmacies (CPs). Their co-morbidities, respiratory symptoms, smoking pack-years and exercise capacity were collected. Airflow limitation was determined using handheld spirometry (COPD-6) device. The prevalence of airflow limitation was 42% (

Indexed as

Chronic Obstructive Pulmonary Disease (COPD), airflow limitationco-morbiditiesprimary caresmoking

Identifiers

PMID29789461
PMCPMC6025281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.